Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone Furoate Growth Study in Children with Allergic Rhinitis
NCT00109486Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2005
- Primary completion
- Nov 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone in allergic rhinitis (AR), sponsored by GSK. Started Apr 2005; status: completed.
02
Drugs
fluticasone
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT00109486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109486.